Edition:
United States

Manojna Maddipatla

Alzheimer's drug from Biogen to get speedy U.S. review

Aug 07 2020

The U.S. Food and Drug Administration will conduct an expedited review of an experimental Alzheimer's drug from Biogen Inc and Japan's Eisai Co Ltd, the companies said on Friday, the first application in 17 years to be reviewed by the agency for a treatment of the mind-robbing disease.

State attorneys general urge U.S. to let other firms make Gilead COVID-19 drug

Aug 04 2020

A bipartisan group of state attorneys general urged the U.S. government on Tuesday to allow other companies to make Gilead Sciences' COVID-19 treatment, remdesivir, to increase its availability and lower the price of the antiviral drug.

Fauci says states seeing surge in COVID-19 cases should reconsider some lockdown measures

Aug 03 2020

The U.S. government's top infectious disease expert, Dr. Anthony Fauci, on Monday said states with high coronavirus case counts should reconsider imposing lockdown restrictions, emphasizing the need to get cases to a low baseline before the fall flu season.

UPDATE 1-Fauci says states seeing surge in COVID-19 cases should reconsider some lockdown measures

Aug 03 2020

Aug 3 The U.S. government's top infectious disease expert, Dr. Anthony Fauci, on Monday said states with high coronavirus case counts should reconsider imposing lockdown restrictions, emphasizing the need to get cases to a low baseline before the fall flu season.

Coronavirus spread among children in Georgia youth camp, CDC says

Jul 31 2020

The coronavirus spread to at least 44% of staff and attendees at an overnight youth camp over a week and a half, the U.S. Centers for Disease Control said in a review of an overnight camp in Georgia.

AbbVie's Humira powers profit beat as COVID-19 weighs on Botox sales

Jul 31 2020

AbbVie Inc on Friday posted a quarterly adjusted profit above estimates as robust sales of its blockbuster arthritis treatment, Humira, helped cushion weak demand for its aesthetic drugs, including Botox, due to the COVID-19 pandemic.

Cigna profit gets boost from lower costs as patients delay surgery

Jul 30 2020

Health insurer Cigna Corp beat Wall Street expectations for second-quarter profit on Thursday, helped by lower medical costs from delayed surgical procedures and strong sales from its pharmacy benefits business.

Anthem profit tops expectations as people delay medical care during pandemic

Jul 29 2020

Anthem Inc reported a quarterly profit that topped Wall Street expectations on Wednesday, aided by lower medical costs as people delayed non-essential procedures during the first surge of the U.S. coronavirus outbreak.

LabCorp says needs to run testing below full capacity for faster results

Jul 28 2020

Laboratory Corporation of America Holdings said on Tuesday it has the capacity to run about 180,000 molecular tests a day and was delivering results in two-three days, but to maintain the speed it will have to perform below full capacity.

World News